Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-007018
Filing Date
2021-02-17
Accepted
2021-02-17 21:06:37
Documents
1
Period of Report
2021-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4097
  Complete submission text file 0000899243-21-007018.txt   5524
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12930 VIA ESPERIA DEL MAR CA 92014
Business Address
Galimi Francesco (Reporting) CIK: 0001823996 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 21647359